Sowell Financial Services LLC Horizon Therapeutics Public LTD CO Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $350,721 - $370,918	3,268 New	3,268 $356,000
Q3 2021 Nov 04, 2021	SELL	$91.91 - $110.37 $1.03 Million - $1.23 Million	-11,158 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$86.24 - $95.92 $1,552 - $1,726	18 Added 0.16%	11,158 $1.05 Million
Q1 2021 May 07, 2021	BUY	$71.83 - $95.48 $193,007 - $256,554	2,687 Added 31.79%	11,140 $1 Million
Q4 2020 Jan 13, 2021	SELL	$67.0 - $84.39 $214,266 - $269,879	-3,198 Reduced 27.45%	8,453 $618,000
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $585,493 - $847,337	10,601 Added 1009.62%	11,651 $905,000
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $30,200 - $56,980	1,000 Added 2000.0%	1,050 $58,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $1,150 - $1,398	50 New	50 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.